I-SPY COVID News Coverage

September 2, 2021

Quantum Leap Concludes Famotidine Celebrex Does Not Reduce Recovery Time in the I-SPY COVID Trial
Read More

April 28, 2021

Quantum Leap Concludes Cenicriviroc Unlikely to Reduce Recovery Time in I-SPY COVID Trial
Read More

April 15, 2021

I-SPY COVID Trial by Quantum Leap Suggests Icatibant not Likely to Impact Critical COVID-19 Patients
Read More

March 12, 2021

Quantum Leap Concludes Apremilast Unlikely to Reduce Recovery or Mortality Time in I-SPY COVID Trial
Read More

March 5, 2021

Quantum Leap Discontinues Testing of Aerpio's Razuprotafib in I-SPY COVID Trial
Read More

December 15, 2020

HHS, DOD engage Quantum Leap Healthcare Collaborative
Read More

September 19, 2020

This theory might explain “Covid toes” and other mysteries of the disease
Read More

August 27, 2020

Oncologists Train ARDS Docs for 'Inspirational' COVID-19 Trial
Read More

July 30, 2020

The COVID R&D Alliance and Quantum Leap Healthcare Enroll First Patients in I-SPY COVID Trials
Read More

May 27, 2020

Quantum Leap Healthcare Selects Aerpio's Razuprotafib for I-SPY COVID Trial for ARDS patients
Read More

April 28, 2020

Dr. Laura Esserman on How to think about your cancer care in the time of COVID-19
Read More

April 28, 2020

Quantum Leap Healthcare Collaborative launches the I-SPY COVID study for ARD's ICU patients
Read More
Portfolio
Quick Links
Quantum Leap Healthcare Collaborative

Quantum Leap Healthcare Collaborative™ is a 501C(3) charitable organization accelerating the union of high-impact clinical research and patient care to improve and save lives.

© 2020 Quantum Leap Healthcare Collaborative.